LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) said members of its management team will present and hold one-on-one meetings at the 44th Annual J.P. Morgan Healthcare Conference, a closely watched gathering that often shapes investor sentiment toward emerging biotechnology companies.
The company’s presentation is scheduled for Wednesday, January 14, at 5:15 p.m. PT, with Chair and Chief Executive Officer Matt Pauls set to address attendees at the Westin St. Francis hotel in San Francisco. The session will take place in the Elizabethan B Room.
Savara said a live webcast of the presentation, along with a replay, will be available through the “Events & Presentations” section of its corporate website and archived for 30 days.
The appearance comes as Savara advances its lead program, MOLBREEVI, a recombinant human granulocyte-macrophage colony stimulating factor being developed for autoimmune pulmonary alveolar proteinosis, a rare and potentially life-threatening lung disease. The therapy is currently in Phase 3 clinical development.
MOLBREEVI is designed for inhaled delivery using a proprietary investigational eFlow Nebulizer System developed by PARI Pharma, a method Savara believes could offer a targeted approach for patients with limited treatment options.
Savara is a clinical-stage biopharmaceutical company focused on rare respiratory diseases, an area that has drawn increasing attention from investors and larger pharmaceutical players seeking differentiated pipelines. The company said its management team brings deep experience in pulmonary medicine and rare disease development, positioning it to identify unmet needs and move therapies through late-stage trials toward potential approval and commercialization.
The J.P. Morgan Healthcare Conference is widely viewed as the industry’s premier annual event, often serving as a platform for companies to highlight clinical progress, outline strategic priorities, and engage directly with institutional investors and potential partners.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.